Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth

A growing body of evidence indicates that PPAR (peroxisome proliferator-activated receptor) α agonists might have therapeutic usefulness in antitumoral therapy by decreasing abnormal cell growth, and reducing tumoral angiogenesis. Most of the anti-inflammatory and antineoplastic properties of PPAR l...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau, Raquel, Díaz-Muñoz, Manuel D., Cacheiro-Llaguno, Cristina, Fresno, Manuel, Iñiguez, Miguel A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490577/
https://www.ncbi.nlm.nih.gov/pubmed/18670614
http://dx.doi.org/10.1155/2008/352437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490577/
https://www.ncbi.nlm.nih.gov/pubmed/18670614
http://dx.doi.org/10.1155/2008/352437

Ejemplares similares